DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer development.
• Hepatocellular carcinoma (HCC) is a major global health concern where lncRNAs are implicated.

Purpose of the Study:

• To elucidate the mechanism of lncRNA inhibition in HCC.
• To determine the contribution of specific lncRNAs to hepatocarcinogenesis.

Main Methods:

• Validation of 35 downregulated lncRNAs (Top35 LNDH) in HCC patient cohorts and cell lines.
• Analysis of promoter methylation status and effect of demethylating agents.
• Assessment of lncRNA expression in different tissues and cell differentiation states.
• Investigation of lncRNA knockdown effects on hepatic gene expression.
• Correlation analysis with tumor differentiation grade and patient survival.

Main Results:

• Top35 LNDH are significantly downregulated in HCC, associated with promoter hypermethylation.
• Demethylation treatment restored Top35 LNDH expression in HCC cell lines.
• Top35 LNDH are preferentially expressed in adult healthy liver and induced during differentiation.
• Knockdown of Top35 LNDH affected expression of other liver-specific genes.
• Top35 LNDH expression positively correlates with tumor differentiation and better patient prognosis.

Conclusions:

• The identified Top35 LNDH are crucial for establishing the hepatic differentiation signature.
• DNA methylation-mediated downregulation of Top35 LNDH during hepatocarcinogenesis compromises differentiation and patient outcomes.